International Clinical Cytometry Society
Anti-CD38 antibody therapy for patients with relapsed/refractory multiple myeloma: differential mechanisms of action and recent clinical trial outcomes | SpringerLink
Cells | Free Full-Text | The Many Facets of CD38 in Lymphoma: From Tumor–Microenvironment Cell Interactions to Acquired Resistance to Immunotherapy
Double CD38−/CD138− negative multiple myeloma - ScienceDirect
Comparison of CD38-Targeted α- Versus β-Radionuclide Therapy of Disseminated Multiple Myeloma in an Animal Model | Journal of Nuclear Medicine
Multiple myeloma with t(11;14)‐associated immature phenotype has lower CD38 expression and higher BCL2 dependence - Kitadate - 2021 - Cancer Science - Wiley Online Library
CD38 directed therapies for management of multiple myeloma | ITT
CD38, A Target for Immunotherapeutic Approaches in Cancer
CD38 expression and function in NK cells. (A) Role of CD38 in the... | Download Scientific Diagram
New Strategies for Targeting CD38 in Multiple Myeloma Take Root
International Clinical Cytometry Society
![PDF] Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/72ce80f2da87d037624955a597846d530a0c6052/3-Figure1-1.png "PDF] Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma | Semantic Scholar")
PDF] Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma | Semantic Scholar
Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide
Functional multi-omics reveals genetic and pharmacologic regulation of surface CD38 in multiple myeloma | bioRxiv
Cells | Free Full-Text | Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma Model
ePosters - Inecalcitol Stimulates CD38 Expression in Multiple Myeloma and Acute Myeloid Leukemia Cell Lines
A Guide to Plasma Cell Markers | Biocompare: The Buyer's Guide for Life Scientists
Pre-treatment CD38-positive regulatory T cells affect the durable response to daratumumab in relapsed/refractory multiple myeloma patients | Haematologica
Blood and Hematology - CD38 Antibodies in Multiple Myeloma: Mechanisms of Action and Modes of Resistance MM cells express high levels of CD38, while CD38 is expressed at relatively low levels on
Detect CD38 expression during anti-CD38 therapy – Caltag Medsystems
Frontiers | CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma
CD38, A Target for Immunotherapeutic Approaches in Cancer
Cells | Free Full-Text | CD38 Expression by Myeloma Cells and Its Role in the Context of Bone Marrow Microenvironment: Modulation by Therapeutic Agents
